TOL — Toleranzia AB Share News
0.000.00%
Last trade - 00:00- SEK126.81m
- SEK121.39m
Brief: Toleranzia Q4 Net Income SEK -1.909 Million
Brief: Toleranzia Completes GLP Toxicology Study Of TOL2
Brief: Toleranzia Enters Into Agreement With Contract Manufacturer Curia
Brief: Toleranzia Q3 Net Income SEK -1.099 Million
Brief: Toleranzia Appoints Thomas Pålsson As CFO
Brief: Toleranzia Announces Outcome In Rights Issue
Brief: Toleranzia Q2 Net Income at SEK -2.503 Million
Brief: Toleranzia Carries Out Rights Issue Of Units Of About SEK 55 Million
Brief: Toleranzia Q1 Loss After Financial Items Narrows To SEK 1.9 Mln
Brief: Toleranzia Files Patent Application For Tolerogen Combination Treatments
Brief: Toleranzia Q4 Loss After Financial Items Widens To SEK 2.2 Mln
Brief: Toleranzia Selects CRL For GLP Toxicology Study Of Its Drug Candidate TOL2
Brief: Toleranzia BoD Recommends Shareholders Not To Accept Mandatory Bid By Flerie Invest
Brief: Flerie Invest Makes Cash Offer To Shareholders In Toleranzia
Brief: Flerie Invest Says Total Holding In Toleranzia Following Acquisition Amounts To 33.5 Million Shares, Comprising 30.4% Of Total Amount Of Shares
Brief: Toleranzia Q3 Net Loss Widens To SEK 2.1 Mln
Brief: Toleranzia Q2 Loss After Financial Items At SEK 2.2 Mln
Brief: Toleranzia Appoints Torbjörn Sannerstedt As New CFO
Brief: Toleranzia Drug Candidate Has Positive Results Published